Mingyan Hou Hallen

Mingyan Hou Hallen (MD, PhD) is a specialist physician in general medicine and has been working as principal investigator and co-investigator at CTCs’ GoCO site since 2023. She has 10 years research experience from both academia and industry. Mingyans’ interest is especially within endocrinology, pulmonary medicine and cardiovascular disease.

Latest publications

Simultaneous generation of cytomegalovirus-specific CD8+ and CD4+ T lymphocytes by use of dendritic cells comodified with pp65 mRNA and pp65 protein 21 October, 2005

Nociceptin immunoreactivity and receptor mRNA in the human trigeminal ganglion 28 February, 2003

UDP acts as a growth factor for vascular smooth muscle cells by activation of P2Y(6) receptors 1 February, 2002

Potent P2Y6 receptor mediated contractions in human cerebral arteries 9 May, 2003

The stable pyrimidines UDPbetaS and UTPgammaS discriminate between contractile cerebrovascular P2 receptors 5 January, 2003

Capsaicin receptor immunoreactivity in the human trigeminal ganglion 27 September, 2002

Neuropeptide expression in the human trigeminal nucleus caudalis and in the cervical spinal cord C1 and C2

5-HT(1B) and 5-HT(1D) receptors in the human trigeminal ganglion: co-localization with calcitonin gene-related peptide, substance P and nitric oxide synthase

Cytokines induce upregulation of vascular P2Y(2) receptors and increased mitogenic responses to UTP and ATP

Characterization of contractile P2 receptors in human coronary arteries by use of the stable pyrimidines uridine 5'-O-thiodiphosphate and uridine 5'-O-3-thiotriphosphate

Angiotensin II type 1 receptors stimulate protein synthesis in human cardiac fibroblasts via a Ca2+-sensitive PKC-dependent tyrosine kinase pathway

MAPKK-dependent growth factor-induced upregulation of P2Y2 receptors in vascular smooth muscle cells 19 May, 1999

Increase in cardiac P2X1-and P2Y2-receptor mRNA levels in congestive heart failure

Phenotype changes of the vascular smooth muscle cell regulate P2 receptor expression as measured by quantitative RT-PCR 30 July, 1998

We provide our customers with cost-effective advice, conduct and reporting of clinical trials.